Furthermore, our results may have significant therapeutic ramifications for the treatment of CAPS, sepsis, atherosclerosis, Parkinson’s disease, and many other diseases in which excessive NLRP3 inflammasome activation contributes to pathology. Here, NLRP3 is linked to cryopyrin-associated periodic syndrome.